|By Marketwired .||
|July 21, 2014 04:30 PM EDT||
IRVINE, CA -- (Marketwired) -- 07/21/14 -- Masimo (NASDAQ: MASI) announced today that it will release financial results for the second quarter ended June 28, 2014, after the market closes on Thursday, August 7, 2014. The release and conference call date is approximately one week later than Masimo's traditional release timing due to executive calendar conflicts during the month of July. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief Financial Officer.
A live webcast of the conference call will be available online from the investor relations page of the company's corporate website at www.masimo.com. The dial-in numbers are (888) 520-7182 for domestic callers and +1 (706) 758-3929 for international callers. The reservation code for both dial-in numbers is 77154954. After the live webcast, the call will be available on Masimo's website through September 5, 2014. In addition, a telephonic replay of the call will be available through August 22, 2014. The replay dial-in numbers are (800) 585-8367 for domestic callers and +1 (855) 859-2056 for international callers. Please use reservation code 77154954.
Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care-helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies have shown that Masimo SET® outperforms other pulse oximetry technologies, even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow SET® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI). Additional information about Masimo and its products may be found at www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are trademarks or registered trademarks of Masimo Corporation
Feb. 20, 2017 01:00 AM EST Reads: 5,119
Feb. 20, 2017 01:00 AM EST Reads: 738
Feb. 20, 2017 12:45 AM EST Reads: 2,330
Feb. 20, 2017 12:15 AM EST Reads: 869
Feb. 20, 2017 12:00 AM EST Reads: 1,312
Feb. 19, 2017 10:30 PM EST Reads: 6,064
Feb. 19, 2017 09:30 PM EST Reads: 756
Feb. 19, 2017 08:00 PM EST Reads: 2,766
Feb. 19, 2017 06:45 PM EST Reads: 3,087
Feb. 19, 2017 06:15 PM EST Reads: 1,024
Feb. 19, 2017 06:00 PM EST Reads: 1,345
Feb. 19, 2017 05:45 PM EST Reads: 5,309
Feb. 19, 2017 05:45 PM EST Reads: 886
Feb. 19, 2017 05:00 PM EST Reads: 8,091
With billions of sensors deployed worldwide, the amount of machine-generated data will soon exceed what our networks can handle. But consumers and businesses will expect seamless experiences and real-time responsiveness. What does this mean for IoT devices and the infrastructure that supports them? More of the data will need to be handled at - or closer to - the devices themselves.
Feb. 19, 2017 05:00 PM EST Reads: 1,555